title: Renal support during liver transplantation: when to consider it?
abstract: Patients undergoing orthotopic liver transplantation constitute a difficult-to-treat population. They often have multiorgan dysfunction: acute kidney injury, severe water-electrolyte and acid-base imbalances, systemic inflammatory responses, thrombocytopenia, as well as abnormalities of coagulation and fibrinolysis. All of these disorders may be further exacerbated by the surgical procedure, which is lengthy and technically complex, requiring massive blood product and other fluid infusions with a high risk to develop severe lactic acidosis, hyperkalemia, or cerebral edema. These considerations provide a rationale to institute intraoperative renal replacement therapy (ioRRT), at least for the most critically ill, namely, patients with kidney dysfunction, or those in whom one anticipates intraoperative clinical and technical problems. This article discusses the most common indications and strategies for ioRRT, examining their advantages and disadvantages as well as current experiences.
authors.affiliation: Department of Nephrology, Dialysias and Internal Diseases, Medical University of Warsaw, Poland. Electronic address: jrowinska@gmail.com.
authors.forename: J
authors.initials: J
authors.lastname: Matuszkiewicz-Rowińska
authors.forename: J
authors.initials: J
authors.lastname: Małyszko
authors.forename: M
authors.initials: M
authors.lastname: Wieliczko
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage; D001929:Brain Edema / Q000503:physiopathology; D006801:Humans; D006947:Hyperkalemia / Q000503:physiopathology; D007010:Hyponatremia / Q000503:physiopathology; D007668:Kidney / Q000503:physiopathology*; D016031:Liver Transplantation; D017582:Renal Replacement Therapy
chemical_list: D000925:Anticoagulants